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Abstract 
Starting from the of bicyclic proline ester, ethyl exo-2-azabicyclo[2.2.1]heptane-3-carboxylate 
(+)-5  several hydantoines and thiohydantoines were prepared by acidic ring closure of the 
corresponding urea or thiourea derivatives. Enantiomer (-)-5 was reduced to 2-
azanorbornylmethanol 12, which was transformed to 5,8-methanooxazolo- and thiazolo[3,4-
a]pyridine derivatives. The structures, stereochemistry and relative configurations of the 
synthesized compounds were proved by NMR. 
 
Keywords: Bicyclic prolinol, enantioselective synthesis, epimerisation, ring closure,  
1,3-heterocycles  
 
 
 
Introduction 
 
α-Amino acids, both natural and unnatural, play a central part in biology and chemistry.1 They 
are fundamental constituents of proteins and other biologically important compounds and one of 
the most frequently used sources of chiral starting materials for organic synthesis. The synthesis 
and application of bicyclic α-amino acids have received much attention of recent years. Many of 
these amino acids are carriers of pharmaceutical activities,2,3 and they have been used as building 
blocks for the synthesis of conformationally constrained peptides.4 Among them exo-2-
azabicyclo[2.2.1]heptane-3-carboxylic acid has received attention as a conformationally more 
rigid substitute for prolin in biologically active peptides5-7 and in the design of chiral ligands used 
in asymmetric catalysis.8,9 
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 Ester derivatives of prolin exhibit interesting pharmacological effects: the L-proline ester of 
2,6-diisopropylphenol (Propofol) derivative was synthetized by Trapini et al. This prolinate 
highly soluble and stable in water at physiological pH and rapidly hydrolyzed in plazma, could 
have potential as a water-soluble propofol prodrug for parenteral administration.10 Analogues of 
(N-glyoxyl)propyl proline esters and chiral bicyclic proline esters have good binding affinity 
toward FKBP12, suggesting their potential therapeutic utility in treating degenerative disorders 
of the nervous system.11 Prolin esters and prolinol are widely used for the preparation of bicyclic 
oxazolidine,9, 12-18 but its 2-azanorbornane derivatives19,20 have not been extensively investigated.  
 Amino ester 5 can be used as a starting substance for the preparation of other bifunctional 
compounds, e.g. amino acids, 1,2-aminoalcohols21,22 and 1,2-diamines23 and it has a few 
applications in the syntheses of other heterocycles.24,25 
 The synthesis and stereochemistry of bicyclic saturated heterocycles with condensed skeleton 
containing two heteroatoms have been the subject of our study for a long time.26 Previously 
several methods have been published for the preparation of cis- or trans-cycloalkane-fused 1,3-
heterocycles.26 As a continuation of this work our aim was to prepare enantiomeric bicyclic 
prolin esters (−)-5 and (+)-5 and prolinol derivatives and to synthesize some 2-azanorbornane-
fused heterocycles.  
 
 
Results and Discussion 
 
Amino ester (−)-5 and (+)-5 were prepared according to reported methods with small 
modifications. The syntheses of the key intermediate 4, is based on the finding that chiral imines 
with cyclopentadiene gives the [4+2]-cycloadduct. In spite of the reaction is highly exo-
selectivity, the separation of the major exo-isomer in the reaction from its diastereomers was 
accomplished by flash chromatography27, 28. Multigram scale synthesis of the aza-Diels Alder 
adducts ethyl and methyl (1R,3R,4S)-2-[(1S)-1-phenylethyl]-azabicyclo[2.2.1]hept-5-ene-3-
carboxylate has been performed by Andersson et al.9 In this new protocol no purification of the 
intermediates, ethyl and methyl glyoxylate and the imine used for the Diels-Alder reaction, was 
necessary. The authors found that the methyl ester analogue of 4 could be easily recrystallized 
from pentane to afford diastereomerically pure adduct in 56 % yield. The ethyl ester 4 have been 
separated from its diastereomers by column chromatography.  
 Our synthetic route to amino ester 5 is shown in Scheme 1. The synthesis started with 
oxidative cleavage of diethyl L-tartarate with sodium periodate, yielding the product, ethyl 
glyoxylate 1 in 1 h.24 The aza-Diels-Alder reaction between 3 (derived from ethyl glyoxylate 1 
and (S)-(-)-1-phenylethylamine 2) and cyclopentadiene, in the presence of trifluoroacetic acid 
and boron trifluoride diethyl etherate, have been performed in a one-step procedure.9 The crude 
hetero Diels-Alder adduct 4 could not crystallized from pentane, it was purified by column 
chromatography. Hydrogenation of the double bond of 4 and concomitant removal of the 
phenylethyl groups by hydrogenolysis in the presence of Pd(OH)2/C afforded amino ester (−)-5. 
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 The α-amino acid ester (+)-5 was prepared from (R)-(+)-1-phenylethylamine by the same 
method. The enantiomeric purity of amino esters 5 were checked (ee > 99%) by chiral gas 
chromatography.  
 
N
N
EtOOC
Me
Ph
cyclopentadiene BF3. OEt2
TFA / -78 °C
COOEt
Me
Ph
C
O
COOEt
H +
NH2
Me Ph
H2 / Pd / CNH.HCl
COOEt HCl / EtOH
1 2 3
(+)-4(-)-5
1
2
34
5
6
7
s
 
 
Scheme 1 
 
 Reaction of isothiocyanates with amino ester base (−)-5 resulted in the corresponding 
thioureas 6a-d. Thioureas 6a-d were cyclised with ethanolic hydrogen chloride or with aqueous 
hydrochloric acid, resulting in tricyclic 2-thioxo-imidazolidinone 7a-d. When 6a,b were boiled 
in acidic solution, partial isomerization took place resulting in exo-7a,b as the main products, 
which were separated from the endo-7a,b by column chromatography. The m-methoxy and p-
chloro-substituted thioureas 7c,d resulted in only the exo-2-thioxo-imidazolidinone 7c,d, no 
formation of the endo isomer was observed (Scheme 2). 
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Scheme 2 
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 When benzylisocyanate was reacted ester base (+)-5 the corresponding urea 8 was formed 
which was cyclised with ethanolic hydrogen chloride to hydantoin 9. Some related bicyclic 
hydantoins and thiohydantoins has been designed and synthesized in an enantiomeric manner by 
Salvati et al.29 Some of the compounds are potent antagonist to the androgen receptor.30-32 
 When amino ester base (+)-5 was reacted with 2-chloroethyl isothiocyanate, N-thiazoline 
derivative 10 was formed. This intermediate was attempted to cyclise with ethanolic hydrogen 
chloride but the formation of the tetracyclic 11 was not observed.  
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Scheme 3 
 
 The amino alcohol 12 was prepared from amino ester (−)-5 by LiAlH4 reduction.28 12 can be 
used as a chiral ligand for asymmetric transfer hydrogenation of ketones,28 and as a starting 
material for ring-closure reactions.19,20 The synthesis of heterocycle 14 started from the p-
chlorophenyl isothiocyanate adduct of 12. Treatment of thiourea 13 with ethanolic hydrogen 
chloride under reflux provided thiazolidine 14 (Scheme 4). The possible Z-E isomerism of 14 
was not investigated. 
 When amino alcohol 12 was condensed with p-nitrobenzaldehyde in methanol, the reaction 
reached completion within a few hours. After evaporation of the solvent the formation of two 
epimeric oxazolo[1,5-a]pyridine derivatives 15 was observed, of which the two epimers could be 
separated by crystallization. As the NMR spectra indicated, in the major epimer 15 H-3 locates 
on the same side as the bridge carbon C-9 of the norbornene skeleton.  
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Scheme 4  
 
 The 1H and 13C NMR signals of 6a-d, 7a-d, 8−10, and 12−15 were assigned with the help of 
dqf-COSY, multiplicity-edited HSQC and HMBC experiments. The relative stereochemistry of 
the products was deduced mainly from NOESY experiments and proton-proton coupling 
constants. Many of the proton and carbon NMR signals were quite broad at 298 K in DMSO-d6 
(and even more so in CDCl3) due to some fast-intermediate chemical exchange processes such as 
hindered rotation of the substituents  and because of the presence of small, unresolved proton-
proton couplings within the 1H spin system of the 2-azanorbornane moiety. The reaction 
intermediates, e.g. compounds 6, generally displayed broader NMR lines than the ring-closed 
products. In the NMR spectra of each product, only one set of signals was observed indicating 
that any thermodynamically favoured dynamic processes were either relatively fast on the NMR 
time scale at the applied experimental conditions (in DMSO at 298 K at the field of a 500 MHz 
instrument), or slow enough so that additional form(s) do not become clearly detectable in the 
sample within a few hours after dissolution in DMSO. However, many of the 1H NMR signals 
were quite broad possibly due to some fast-intermediate chemical exchange process such as 
hindered rotation of the substituents, and due to the presence of small, unresolved proton-proton 
couplings within the 1H spin system of the 2-azanorbornane moiety. In every case, the NMR 
spectra were consistent with the expected structures. 
 The ethoxycarbonyl substituent is in an exo position in the starting 2-azanorbornanes (−)-5 
and (+)-5 yielding products that are exo substituted at C-8a if the configuration is retained during 
the synthesis. Compounds 6a-d, 7a,b (major products), 7c,d, 8, 9 and 15 (minor product) were 
indeed found to be exo substituted/fused, as deduced from the NOE cross peak between H-8a (or 
H-3 for the intermediates) and the endo-proton at C-7 (C-5 for the intermediates), and from the 
lack of such a cross peak between H-8a (H-3) and the syn-proton at the methylene bridge carbon 
C-9 (C-7). Remarkably, the minor products of 7a and 7b did have the inverted configuration at 
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C-8a resulting in and endo-fused imidazolidine ring, as proven by the NOE correlation between 
H-8a and H-9syn in the NOESY spectra of these compounds. 
 Product 15 exhibited two epimers with respect to the asymmetric carbon C-3, of which the 
major and the minor form could be separated pure by crystallisation. The major and minor 
epimers of 15 were again identified by their NOE correlations. For the major form a strong NOE 
is observed between protons H-9syn and H-3, as well as between H-5 and H-3. Therefore the 
major epimer is the one in which H-3 locates on the same side as the bridge carbon C-9 of the 
norbornene skeleton. In case of the minor epimer of 15 the ortho protons of the p-nitrophenyl 
group (7.70 ppm) displayed and NOE correlation with H-9syn (1.47 ppm) whereas H-3 (5.34 
ppm) was NOE correlated with H-8a (3.28 ppm). This establishes that in the minor epimer the 
aryl group is on the same face of the tricyclic skeleton as the methylene bridge. 
 
 
Experimental Section 
  
General Procedures. Melting points were determined with a Koffler apparatus and are not 
corrected. Merck Kieselgel 60F254 plates were used for TLC: the eluent was toluene-MeOH 4:1. 
Column chromatography was performed on silica gel (Merck 60, 70-230 mesh). NMR-spectra 
were acquired using Bruker Avance 400 and 500 spectrometers (equipped with BBI-5mm-
Zgrad-ATM and BBO-5mm-Zgrad probes) operating at 399.75 and 500.13 MHz for 1H and 
100.53 and 125.77 MHz for 13C, respectively. No sample spinning was used. DMSO-d6 was used 
as solvent with tetramethylsilane (TMS) as an internal standard (δTMS = 0.00 ppm for both 1H 
and 13C), and the probe temperature was set at 298 K. Spectra were processed by a PC with 
Windows XP operating system and XWin-NMR software. 1H NMR spectra were acquired with 
single-pulse excitation using a 30° flip angle, 2.3 µs (BBI) or 3.0 µs (BBO) pulse width, 10.3 
kHz spectral width and 3.17 s acquisition time, and processed with 0.3 Hz exponential weighing 
prior to Fourier transform. 13C NMR spectra were acquired with single-pulse excitation and 
broadband proton decoupling (waltz-16) using a 30° flip angle, 4.2 µs (BBI) or 2.3 µs (BBO) 
pulse width, 30.0 kHz spectral width and 1.09 s acquisition time, and processed with 1.0 Hz 
exponential weighing prior to Fourier transform. The gradient-selected dqf-COSY, NOESY, 
multiplicity-edited HSQC and HMBC 2D NMR experiments were acquired using vendor-
provided pulse programs (cosygpmfqf, noesygpph, hsqcedetgpsisp2 and hmbcgplpndqf, 
respectively). The NOESY mixing time was set at 0.3 s, and the HSQC and HMBC experiments 
were optimized for a one-bond C,H coupling constant of 145 Hz and long-range coupling 
constants of 10 Hz.  
The electron ionization (EI) mass spectra were recorded on a VG ZABSpec mass spectrometer 
(VG Analytical, Division of Fisons, Manchester, UK), that was equipped with Opus V3.3X 
program package (Fisons Instruments, Manchester, UK). The ionization energy was 70 eV and 
source temperature 160 °C. Small samples dissolved in methanol were placed into a quartz 
capillary tube and methanol was evaporated with hot air. Thereafter the sample was taken into 
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the ionization chamber via the solid insertion probe. Perfluorokerosine (PFK) was used for 
calibration of the mass scale. The elemental compositions of the molecular ions were determined 
by peak matching (10% valley definition) using 10000 resolution. 
Cyclopentadiene was obtained from its dimer by heating at 200 °C. The ee values of the esters 
(+)-5 and (−)-5 were determined by gas chromatography on a Chrompack CP Chiracel-Dex CB 
column (25 m). Amino esters (−)-5 and (+)-5 were derivatised with acetic anhydride in the 
presence of 4-dimethylaminopyridine (DMAP) and pyridine (P) before the gas chromatographic 
analysis. To a solution of ester 5 (1 mg in 0,1 mL CH2Cl2) 15 µL DMAP/P (1:9) and 15 µL 
Ac2O was added; [80 °C for 5 min →130 °C (rate of temperature rise 20 °C/min; 70 kPa, carrier 
gas N2, Tinj. 250 °C, Tdet. 270 °C), retention times (min): (−)-5: 12.42; (+)-5: 12.71]. Optical 
rotations were measured with a Perkin-Elmer 341 polarimeter.  
 
Ethyl (1S,3R,4R)-2-azabicyclo[2.2.1]heptane-3-carboxylate hydrochloride (−)-5 and ethyl 
(1R,3S,4S)-2-azabicyclo[2.2.1]heptane-3-carboxylate hydrochloride (+)-5.  
To a magnetically stirred aqueous solution of diethyl L-(+)-tartrate (6.8 g, 33 mmol in 50 mL), 
one equivalent of NaOI4 was added at 0 ºC during 15 min. The mixture was stirred for one hour 
at the same temperature and evaporated. The residue was dissolved in CH2Cl2, dried (Na2SO4) 
and evaporated. The produced ethyl glyoxylate (5.1 g 50 mmol) was dissolved in CH2Cl2, 
molecular sieves (2 g, 4Ǻ) were added under argon atmosphere and the mixture was cooled to 4 
°C. (S)-(−)-1-Phenylethylamine (6.2 g, 51 mmol) was added and the mixture was stirred for 1 h. 
The water bath was replaced with a dry ice/isopropanol bath with an external cooler and the 
reaction mixture was cooled to −78 °C. A solution of imine 3 was sequentially treated with 
CF3COOH (4 mL, 52 mmol), BF3.Et2O (6.6 mL, 52 mmol) and with freshly distilled 
cyclopentadiene (5.1 mL). When the addition was complete the reaction mixture was stirred for 8 
h at −75 °C and the mixture was thereafter allowed to warm to ambient temperature. When the 
room temperature was reached the mixture, it was poured into a saturated aqueous solution of 
Na2CO3. The resulting mixture was stirred for 2 h and filtered then through a pad of Celite and 
the residue washed with CH2Cl2 (2x 50 mL). The layers were separated and the aqueous phase 
extracted with CH2Cl2 (2x 50 mL). The organic phases was dried (MgSO4), and evaporated to 
give the crude Diels-Alder adduct 4, which was purified by column chromatography on silica gel 
using n-hexane/ethyl acetate (9:1) (6.86 g, 52 %) [α] 25D = +86.0 (c 1, MeOH). The major 
diastereomer 4 (6 g, 22 mmol) was hydrogenated over Pd(OH)2/C (5%, 0.5 g) in abs. EtOH (100 
mL) at 50 bar initial H2 pressure. After 3 days the mixture was filtered off and the residue 
washed with abs. EtOH. To the filtrate ethanolic HCl (5 mL, 22%) was added and the mixture 
was then evaporated. The residue was crystallized with Et2O and recrystallized from EtOH/Et2O. 
(−)-5: White crystals mp 148-149 ºC yield 3.0 g, (66%) Lit mp28: 153-154 ºC [α] 25D = −15.9 (c 1, 
MeOH) Lit [α] 25D = −16.3 (c 1, MeOH) 27 The (+)-5 amino ester hydrochloride was prepared from 
(R)-(+)-1-phenylethylamine by the same method. White crystals mp 148-149 ºC Lit mp28 153-
154 ºC [α] 25D = +18.8 (c 1, MeOH) Lit [α]
25
D = +16.2 (c 1, MeOH)
28 1H NMR (DMSO-d6) δ (ppm): 
1.25 (3H, t, J = 7.1 Hz, OCH2CH3,), 1.54-1.70 (5H, m, H-5, H-6, H-7), 1.93 (1H, brt, J = 10.3 
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Hz, H-6), 2.87 (1H, brd, J = 3.4 Hz, H-4), 4.02 (1H, s, H-3), 4.05 (1H, brs, H-1), 4.23 (2H, m, 
OCH2CH3). 13C NMR (DMSO-d6) δ (ppm): 13.8 (OCH2CH3), 24.3 (C-6), 26.1 (C-7), 34.7 (C-5), 
39.8 (C-4), 58.2 (C-1), 61.6 (C-3), 62.3 (OCH2CH3), 168.3 (C=O). M+•(6) C9H15NO2+• Calcd 
169.1103 Obsd 169.1104 Other ions m/z (%): 96(100), 68(66), 67(11), 41(11) 
 
General procedure the synthesis of urea and thiourea derivatives 6a-d and 8 
One equivalent of the corresponding isothiocyanate or isocyanate was added to 0.5 g (2.96 
mmol) (+)-5 or (−)-5 bases, dissolved in 20 mL toluene. The mixture was stirred overnight then 
was evaporated, n-hexane was added, and the crystalline products 6b-d and 8 were filtered off 
and recrystallized. The oily 6a was purified by column chromatography. 
 
Ethyl (1S,3R,4R)-2-ethylthiocarbamoyl-2-azabicyclo[2.2.1]heptane-3-carboxylate (6a). Oil, 
(n-hexane/EtOAc = 3:1); yield 0.48 g, (64 %); [α] 25D  = +135.7 (c 1, MeOH) 
1H NMR (DMSO-d6) 
δ (ppm): 1.08 (3H, t, J = 6.9 Hz, NCH2CH3), 1.18 (3H, t, J = 7.0 Hz, OCH2CH3,), 1.39-1.44 (2H, 
m, H-5, H-7), 1.49 (1H, brm, H-6), 1.60 (1H, brm, H-6), 1.72 (1H, m, H-5), 1.92 (1H, brm, H-7), 
2.54 (1H, brs, H-4), 3.46 (2H, brm, NCH2CH3), 4.07 (2H, brq, J = 7.0 Hz, OCH2CH3), 4.22 (1H, 
brs, H-3), 4.55 (1H, brs, H-1), 7.61 (1H, brs, NH). 13C NMR (DMSO-d6) δ (ppm): 14.0 
(OCH2CH3), 14.5(NCH2CH3), 27.2(C-5), 28.8 (C-6), 35.2 (C-7), 39.5 (NCH2CH3), 40.9 (C-4), 
57.3 (C-1), 60.0 (OCH2CH3), 69.0 (C-3), 170.0 (C=O), 178.3 (C=S). M+•(100) C12H20N2O2S+•  
Calcd 256.1246 Obsd 256.1256 Oher ions m/z (%): 210(14), 183(16), 169(15), 144(13), 
140(29), 96(65), 95(12), 68(45), 67(10), 60(15), 44(2) 
Ethyl (1S,3R,4R)-2-(4-methoxyphenylthiocarbamoyl)-2-azabicyclo[2.2.1]heptane-3-carbo-
xylate (6b). White crystals, mp 185-186 ºC (EtOAc); yield 0.63 g, (64 %); [α] 25D = +80.3 (c 0.5, 
EtOH) 1H NMR (DMSO-d6) δ (ppm): 1.19 (3H, t, J = 7.1 Hz, OCH2CH3,), 1.48 (1H, Br d, J = 
9.9 Hz, H-7anti), 1.51(1H, m, H-5endo), 1.63-1.73 (2H, m, H-6exo, H-6endo), 1.77 (1H, m, H-
5exo), 2.02 (1H, m, H-7syn), 2.61 (1H, brs, H-4), 3.74 (3H, s, p-OCH3) 4.08 (2H, q, J = 7.0 Hz, 
OCH2CH3), 4.31 (1H, brs, H-3), 4.82 (1H, brs, H-1), 6.87 (2H, m, m-Ar), 7.22 (2H, m, o-Ar), 
9.16 (1H, brs, NH). 13C NMR (DMSO-d6) δ (ppm): 14.0 (OCH2CH3), 27.2 (C-5), 29.2 (C-6), 
35.4 (C-7), 41.0 (C-4), 55.1 (p-OCH3), 58.4 (C-1), 60.1 (OCH2CH3), 69.4 (C-3), 113.1 (m-Ar), 
127.6 (o-Ar), 1331. (i-Ar), 156.5 (p-Ar), 169.8 (C=O), 178,5 (C=S). M+•(87) C17H22N2O3S+•  
Calcd 334.1351; Obsd 334.1353.Other ions m/z (%): 301(13), 289(12), 288(40), 212(30), 
195(11), 184(11), 167(14), 166(20), 165(100), 150 (26), 140 (51), 138(14), 125(11.5), 123(26), 
122(22), 108(18), 96(90), 95(11), 79(29), 68(41), 67(17), 41(12) 
Ethyl (1S,3R,4R)-2-(3-methoxyphenylthiocarbamoyl)-2-azabicyclo[2.2.1]heptane-3-carbo-
xylate (6c). White crystals, mp 102-104 ºC (EtOAc); yield 0.73 g, (74 %); [α] 25D = +82.4 (c 0.5, 
MeOH) 1H NMR (DMSO-d6) δ (ppm): 1H NMR (DMSO-d6) δ (ppm): 1.19 (3H, t, J = 7.1 Hz, 
OCH2CH3), 1.48 (1H, brd, J = 9.9 Hz, H-7anti), 1.51 (1H, m, H-5endo), 1.62-1.73 (2H, m, H-
6exo, H-6endo), 1.78 (1H, m, H-5exo), 2.02 (1H, m, H-7syn), 2.62 (1H, brs, H-4), 3.73 (3H, s, 
m-OCH3), 4.09 (2H, q, J = 7.0 Hz, OCH2CH3), 4.33 (1H, brs, H-3), 4.86 (1H, brs, H-1), 6.70 1H, 
m, p-Ar), 6.98 (1H, m, o’-Ar), 7.04 (1H, brs, o-Ar), 7.20 (1H, t, J = 8.1 Hz, m’-Ar), 9.24 (1H, 
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brs, NH). 13C NMR (DMSO-d6) δ (ppm): 14.0 (OCH2CH3), 27.2 (C-5), 29.4 (C-6), 35.4 (C-7), 
41.0 (C-4), 55.0 (m-OCH3), 58.8 (C-1), 60.1 (OCH2CH3), 69.3 (C-3), 110.1 (o-Ar), 111.1 (p-Ar), 
117.6 (o’-Ar), 128.5 (m’-Ar), 141.3 (i-Ar), 158.8 (m-Ar), 169.7 (C=O), 177.9 (C=S). M+•(100) 
C17H22N2O3S+•  Calcd 334.1351; Obsd 334.1356. Other ions m/z (%): 333(15), 301(10), 289(7), 
288(9), 261(7), 212(20), 195(8), 184(5.5), 169(10), 166(14.5), 165(23), 140(17), 138(6), 
123(15), 96(60), 95(7), 79(14), 77(13), 68(29), 67(9), 41(7) 
Ethyl (1S,3R,4R)-2-(4-chlorophenylthiocarbamoyl)-2-azabicyclo[2.2.1]heptane-3-carbo-
xylate (6d). White crystals, mp 60-62 ºC (EtOAc); yield 0.66 g, (68 %); [α] 25D = +92.9 (c 0.5, 
MeOH) 1H NMR (DMSO-d6) δ (ppm): 1.19 (3H, t, J = 7.1 Hz, OCH2CH3), 1.49 (1H, brd, J = 
10.0 Hz, H-7anti), 1.51 (1H, m, H-5endo), 1.62-1.73 (2H, m, H-6exo, H-6endo), 1.78 (1H, m, H-
5exo), 2.03 (1H, m, H-7syn), 2.63 (1H, br~s, H-4), 4.09 (2H, q, J = 7.0 Hz, OCH2CH3), 4.31 
(1H, brs, H-3), 4.86 (1H, brs, H-1), 7.35 (2H, m, m-Ar), 7.42 (2H, m, o-Ar), 9.35 (1H, brs, NH). 
13C NMR (DMSO-d6) δ (ppm): 14.0 (OCH2CH3), 27.1 (C-5), 29.4 (C-6), 35.4 (C-7), 41.0 (C-4), 
58.9 (C-1), 60.2 (OCH2CH3), 69.4 (C-3), 127.2 (o-Ar), 127.7 (m-Ar), 128.5 (p-Ar), 139.2 (i-Ar), 
169.6 (C=O), 177.9 (C=S). M+•: 340(24); 338(64) Calcd 338.0856; Obsd 338.0860. Other ions 
m/z (%): 305(5.5), 292(24), 265(6), 212(33), 171(24), 169/73.5), 140 (18), 138(11.5), 127(19.5), 
111(24), 96(100), 95(18), 79(21), 75(13), 68(57), 67(19), 41(13) 
Ethyl (1R,3S,4S)-2-(benzylcarbamoyl)-2-azabicyclo[2.2.1]heptane-3-carboxylate (8). White 
crystals, mp: 92-94 ºC (n-hexane/EtOAc), yield 0.61 g, (69 %); [α] 25D  = −82.6 (c 0.5, EtOH) 1H 
NMR (DMSO-d6) δ (ppm): 1.18 (3H, t, J = 7.2 Hz, OCH2CH3), 1.31 (1H, brd, J = 9.6 Hz, H-7), 
1.43 (1H, m, H-5), 1.52-1.61 (2H, m, H-6), 1.69 (1H, m, H-5), 1.74 (1H, brm, H-7), 2.58 (1H, 
brs, H-4), 3.78 (1H, brs, H-3), 4.01-4.11 (2H, m, OCH2CH3), 4.16 (1H, dd, J = 15.5, 5.7 Hz, 
NCH2), 4.26-4.30 (2H, m, H-1, NCH2), 6.96 (1H, brs, NH), 7.20 (1H, m, p-Ar), 7.24 (2H, m, o-
Ar), 7.30 (2H, m, m-Ar). 13C NMR (DMSO-d6) δ (ppm): 14.0 (OCH2CH3), 27.3 (C-5), 29.7 (C-
6), 35.0 (C-7), 41.2 (C-4), 43.0 (NCH2), 55.7 (C-1), 60.0 (OCH2CH3), 63.7 (C-3), 126.3 (p-Ar), 
126.7 (o-Ar), 128.0 (m-Ar), 140.9 (i-Ar), 155.8 (NH-C=O), 170.9 (O-C=O). M+•(22) 
C17H22N2O3+•  Calcd 302.1630 Obsd 302.1639 Other ions m/z (%): 256(38), 229(17), 228(11), 
106(12), 96(100), 91(58), 68(44), 67(22), 65(11), 54(11), 41(12) 
 
General procedure of thiohydantoines 7a-d and hydantoine 9 
Compound 6a-d or 8 (2.5 mmol) was refluxed in 25 mL EtOH containing 20% dry HCl for 5 h. 
The reaction mixture was evaporated, diethyl ether was added, and the crystalline products 7c, d 
were filtered off and recrystallized. The epimers of 7a and 7b were separated by column 
chromatography (n-hexane/EtOAc 5:1). 
5,8,8a-Hexahydro-2-ethyl-3-thioxo-5,8-methanoimidazo[1,5-a]pyridine-1(5H)-one (7a).  
(5S,8R,8aR)-7a (major epimer). oil (EtOAc), yield 0.21 g, (41%); [α] 25D  = +109.0 (c 0.5, 
MeOH) 1H NMR (DMSO-d6) δ (ppm): 1.09 (3H, t, J = 7.1 Hz, NCH2CH3), 1.10 (1H, brm, H-
9syn), 1.32 (1H, brd, J= 10.6 Hz, H-9anti), 1.64-1.72 (3H, m, H-7, H-7, H-6), 1.80 (1H, m, H-6), 
2.81 (1H, brs, H-8), 3.68 (2H, q, J = 7.2 Hz, NCH2), 3.95 (1H, s, H-8a), 4.64 (1H, brd, J = 3.5 
Hz, H-5). 13C NMR (DMSO-d6) δ (ppm): 12.3 (NCH2CH3), 26.4 (C-6), 28.3 (C-7), 34.8 (C-9), 
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36.3 (NCH2), 39.1 (C-8), 65.2 (C-5), 67.3 (C-8a), 174.4 (C-1), 192.3 (C-3). M+•(100)  
C10H14N2OS+•  Calcd 210.0827 Obsd 210.0836 Other ions m/z(%): 144(11), 141(27), 96(12), 
95(10), 68(24), 67(20), 54(14), 41(11) 
(5S,8R,8aS)-7a (minor epimer). White crystals, mp 62-63 ºC, yield 57 mg, (11%); [α] 25D  = 
+100.1 (c, 0.5 MeOH)1H NMR (DMSO-d6) δ (ppm): 0.97 (1H, m, H-7endo), 1.10 (3H, t, J = 7.1 
Hz, NCH2CH3), 1.53 (1H, m, H-6exo), 1.64 (1H, m, H-7exo), 1.80 (1H, m, H-9anti), 2.05-2.11 
(2H, m, H-6endo, H-9), 2.85 (1H, brs, H-8), 3.63-3.73 (2H, m, NCH2), 4.36 (1H, brs, H-5), 4.54 
(1H, dd, J = 3.6, 1.4 Hz, H-8a). 13C NMR (DMSO-d6) δ (ppm): 12.6 (NCH2CH3), 21.3 (C-7), 
27.2 (C-6), 36.0 (NCH2), 37.6 (C-8), 39.7 (C-9), 61.9 (C-5), 70.4 (C-8a), 172.9 (C-1), 187.8 (C-
3). M+•(56)  C10H14N2OS+•  Calcd 210.0827 Obsd 210.0830 Other ions m/z(%): 144(100), 
141(6), 96(5), 68(15), 67(16), 41(8) 
5,8,8a-Hexahydro-2-(4-methoxyphenyl)-3-thioxo-5,8-methanoimidazo[1,5-a]pyridine-
1(5H)-one (7b). 
(5S,8R,8aR)-7b (major epimer). White crystals, mp 183-184 ºC (EtOAc), yield 0.42 g, (58 
%);[α] 25D  = +63.4 (c 0.5, EtOH) 
1H NMR (DMSO-d6) δ (ppm): 1.38-1.44 (2H, m, H-9syn, H-
9anti), 1.69-1.76 (3H, m, H-7, H-7, H-6), 1.85 (1H, m, H-6), 2.91 (1H, brs, H-8), 3.80 (3H, s, p-
OCH3), 4.13 (1H, s, H-8a), 4.72 (1H, brd, J = 3.6 Hz, H-5), 7.02 (2H, m, m-Ar), 7.19 (2H, m, o-
Ar). 13C NMR (DMSO-d6) δ (ppm): 26.4 (C-6), 28.3 (C-7), 35.3 (C-9), 39.4 (C-8), 55.3 (p-
OCH3), 65.5 (C-5), 67.7 (C-8a), 114.0 (m-Ar), 126.2 (i-Ar), 129.5 (o-Ar), 159.2 (p-Ar), 174.2 
(C-1), 192.6 (C-3). M+•(91) C15H15N2O2S+•  Calcd 288.0932 Obsd 288.0943 Other ions m/z 
(%): 255(10), 222(5), 166(11), 165(100), 150(17), 149(15), 134(13), 133(6), 122(9), 67(8) 
(5S,8R,8aS)-7b (minor epimer). White crystals, mp 105-107 ºC (EtOAc), yield 86 mg, (12 %); 
[α] 25D  = −57.0 (c 0.5, EtOH) 1H NMR (DMSO-d6) δ (ppm) 1.25 (1H, m, H-7endo), 1.60 (1H, m, 
H-6exo), 1.73 (1H, m, H-7exo), 1.85 (1H, m, H-9anti), 2.15 (1H, m, H-9syn), 2.25 (1H, m, H-
6endo), 2.92 (1H, m, H-8), 3.80 (3H, s, p-OCH3), 4.43 (1H, brs, H-5), 4.72 (1H, dd, J = 3.6, 1.4 
Hz, H-8a), 7.02 (2H, m, m-Ar), 7.17 (2H, m, o-Ar). 13C NMR (DMSO-d6) δ (ppm): 21.5 (C-7), 
27.4 (C-6), 37.8 (C-8), 39.9 (C-9), 55.3 (p-OCH3), 62.3 (C-5), 70.8 (C-8a), 114.0 (m-Ar), 126.0 
(i-Ar), 129.6 (o-Ar), 159.2 (p-Ar), 172.8 (C-1), 188.1 (C-3). M+•(76) C15H15N2O2S+•  Calcd 
288.0932 Obsd 288.0944 Other ions m/z (%): 255(3) 222(100), 166(8), 165(54), 150(17), 
149(12.5), 134(12), 133(10), 122(10), 67(10) 
(5S,8R,8aR)-5,8,8a-Hexahydro-2-(3-methoxyphenyl)-3-thioxo-5,8-methanoimidazo[1,5-
a]pyridine-1(5H)-one (7c). White crystals, mp 126-127 ºC (EtOAc), yield (0.53 g, (73%); [α] 25D  
= +42.6 (c 0.5, MeOH) 1H NMR (DMSO-d6) δ (ppm): ): 1.40 (1H, brd, J = 10.6 Hz, H-9anti), 
1.46 (1H, m, H-9syn), 1.69-1.76 (3H, m, H-7, H-7, H-6), 1.85 (1H, m, H-6), 2.92 (1H, brs, H-8), 
3.76 (3H, s, m-OCH3), 4.13 (1H, s, H-8a), 4.73 (1H, br d, J = 3.4 Hz, H-5), 6.84 (1H, m, o’-Ar), 
6.89 (1H, m, o-Ar), 7.02 (1H, m, p-Ar), 7.39 (1H, t, J = 8.1 Hz, m’-Ar). 13C NMR (DMSO-d6) δ 
(ppm): 26.4 (C-6), 28.3 (C-7), 35.3 (C-9), 38.9-39.9 (C-8, under DMSO), 55.3 (m-OCH3), 65.6 
(C-5), 67.8 (C-8a), 114.2 (o-Ar), 114.3 (p-Ar), 120.4 (o’-Ar), 129.5 (m’-Ar), 134.7 (i-Ar), 159.4 
(m-Ar), 173.9 (C-1), 192.0 (C-3). M+•(100) C15H16N2O2S2+•  Calcd 288.0932 Obsd 288.0942 
Other ions m/z (%): 287(6), 254(5), 222(9), 166(14), 166(11), 165(98), 95(20), 77(10), 67(10.5) 
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(5S,8R,8aR)-5,8,8a-Hexahydro-2-(4-chlorophenyl)-3-thioxo-5,8-methanoimidazo[1,5-
a]pyridine-1(5H)-one (7d). White crystals, mp 155-157 ºC (EtOAc), yield 0.49 g, (67%); [α] 25D  
= +48.2 (c 0.5, MeOH) 1H NMR (DMSO-d6) δ (ppm): 1.40 (1H, brd, J = 10.5 Hz, H-9anti), 1.48 
(1H, m, H-9syn), 1.70-1.76 (3H, m, H-7, H-7, H-6), 1.86 (1H, m, H-6), 2.92 (1H, brs, H-8), 4.15 
(1H, s, H-8a), 4.73 (1H, brd, J = 3.2 Hz, H-5), 7.36 (2H, m, o-Ar), 7.57 (2H, m, m-Ar). 13C NMR 
(DMSO-d6) δ (ppm): 26.4 (C-6), 28.3 (C-7), 35.4 (C-9), 38.9-39.9 (C-8, under DMSO), 65.6 (C-
5), 67.9 (C-8a), 128.9 (m-Ar), 130.3 (o-Ar), 132.5 (p-Ar), 133.4 (i-Ar), 173.8 (C-1), 191.6 (C-3). 
M+•(100) C15H16N2O2S2+•  Calcd 292.0437 Obsd 292.0444 Other ions m/z (%): 229(12), 
226(10), 171(29), 169(79), 111(12.5), 95(45.5), 68(17), 67(19), 54(10), 41(10) 
(5R,8S,8aS)-5,8,8a-tetrahydro-2-benzyl-5,8-methanoimidazo[1,5-a]pyridine-1,3(2H,5H)-
dione (9). White crystals, mp 85-86 ºC (EtOAc), yield 0.47 g, (73%); [α] 25D  = −78.1 (c 0.5, 
MeOH) 1H NMR (DMSO-d6) δ (ppm): 1.07 (1H, m, H-9), 1.30 (1H, brd, J= 10.7 Hz, H-9), 1.50-
1.58 (2H, m, H-6, H-7), 1.63 (1H, m, H-7), 1.70 (1H, m, H-6), 2.75 (1H, brd, J= 2.8 Hz, H-8), 
3.82 (1H, br s, H-8a), 4.22 (1H, brd, J= ~2.4 Hz, H-5), 4.51 (1H, d, J= 15.2 Hz, NCH2), 4.54 
(1H, d, J= 15.2 Hz, NCH2), 7.24 (2H, m, o-Ar), 7.28 (1H, m, p-Ar), 7.33 (2H, m, m-Ar). 13C 
NMR (DMSO-d6) δ (ppm): 27.0 (C-6), 27.7 (C-7),  34.5 (C-9), 38.8 (C-8), 41.8 (NCH2), 60.4 
(C-5), 65.8 (C-8a), 127.3 (o-Ar), 127.5 (p-Ar), 128.5 (m-Ar), 136.2 (i-Ar),163.2 (C-3), 173.9 (C-
1). M+•(100) C15H16N2O2+•  Calcd 256.1222 Obsd 256.1212 Other ions m/z (%): 228(22), 
132(11), 96(18), 95(12), 91(57), 68(19), 678189, 54(14) 
Ethyl (1R,3S,4S)-2-(4,5-dihydro-thiazol-2-yl)-2-azabicyclo[2.2.1]heptane-3-carboxylate (10). 
It was prepared from base (+)-5 (0.5 g, 2.96 mmol) in 20 mL with one equivalent of the 
chloroethylisothiocyanate33 as described for 6. The oily product was purified by column 
chromatography. Oil, (toluene: methanol = 4:1), yield 0.64 g, (85%); [α] 25D  = −193.1 (c 1, 
MeOH) 1H NMR (DMSO-d6) δ (ppm): 1.22, (3H, t, J = 7.1, OCH2CH3), 1.52 (1H, brd, J = 11.0, 
H-7), 1.62 (1H, brm, H-5), 1.65-1.70 (2H, brm, H-6), 1.75 (1H, brm, H-7), 1.77 (1H, brm, H-5), 
2.86 (1H, brd, J  = 2.8, H-4), 3.58 (2H, brm, CH2S), 3.92 (2H, brt, J=7.3Hz, NCH2), 4.12 (1H, 
brs, H-1), 4.17 (3H, q, J = 7.1, OCH2CH3), 4.21 (1H, brs, H-3). 13C NMR (DMSO-d6) δ (ppm): 
13.8 (OCH2CH3), 25.8 (C-5), 28.9 (C-6), 32.5 (CH2S), 35.1 (C-7), 42.0 (C-4), 50.8 (CH2N), 61.4 
(OCH2CH3, 68.0 and 68.3 (C-1 and C-3), 176.8 (C=O). M+•(27) C12H18N2O2S+•  Calcd 254.1089 
Obsd 254.1083 Other ions m/z (%): 182(21), 181(100), 153(62) 
(1S,3R,4R)-3-Hydroxymethyl-2-azabicyclo[2.2.1]heptane (12). To a slurry of LiAlH4 (1.5 g, 
39.55 mmol) in 50 mL of dry THF, amino ester base (−)-5 (4.25 g, 25 mmol) in 20 mL of THF 
was added dropwise at room temperature. After stirring one hour, the mixture was decomposed 
with 2 mL of water under ice cooling. The inorganic material was filtered off and washed with 
THF. After drying and evaporation, the resulting oil was crystallized from n-hexane and 
recrystallized. White crystals, mp 126-127 ºC (iPr2O) yield (1.8 g, 57%; [α] 25D  = −61.9 (c 0.5, 
MeOH) Lit: [α] 25D  = −62.9 (c 1, CHCl3)28 1H NMR (DMSO-d6) δ (ppm): 1.39, (1H, td, J = 9.0, 
1.9 Hz, H-5,) 1.47 (1H, d J = 10.9 Hz, H-7), 1.61 (1H, dd, J = 3.3, J = 12.2 Hz, H-6), 1.66 (1H, 
dd, J = 3.5, J = 12.2 Hz, H-6), 1.75 (2H, m, H-5, H-7), 2.41 (1H, brs, H-4), 3.16 (1H, dd, J = 5.5, 
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J = 7.9 Hz, H-3), 3.39 (1H, dd, J = .2, J= 11.6 Hz, CH2OH), 3.66 (1H, dd, J = 5.5, J = 11.6 Hz, 
CH2OH), 3.89 (1H, brs, H-1), 8.70 (1H, brs, NH). 13C NMR (DMSO-d6) δ (ppm): 25.0 (C-6), 
27.1 (C-5), 34.4 (C-7), 37.0 (C-4), 56.8 (C-1), 60.2 (CH2OH), 64.2 (C-3). M+•(3.5) C7H13NO+•  
Calcd 127.0997 Obsd 127.0991 Other ions m/z (%): 95(84), 68(100), 67(11), 41(16)  
(1S,3R,4R)-1-(4-Chlorophenyl)-3-(3-hydroxymethyl-bicyclo[2.2.1]hept-2-yl thiourea (13). It 
was prepared from amino alcohol 12 (0.4 g, 3.14 mmol in 20 mL), with p-
chlorophenylisothiocyanate  as described for 6. White crystals, mp 189-190 ºC (EtOAc) yield 
0.61 g, (66%); [α] 25D  = +198.5 (c 0.5, MeOH) 
1H NMR (DMSO-d6) δ (ppm): 1.2-2.0 (6H, m, H-
5, H-6, H-7), 3.17 (1H, d J = 5.0, Hz, H-4), 3.61 (1H, m, H-3), 3.61-3.66 (2H, m, CH2OH), 4.83 
(1H, brs, H-1), 7.33 (2H, m, m-Ar), 7.49 (2H, brd, J = 7.6 Hz, o-Ar). 13C NMR (DMSO-d6) δ 
(ppm): 27.1 (C-6), 28.7 (C-5), 35.0 (C-7), 41.1 (C-4), 62.7 (C-1), 65.3 (CH2OH), 70.0 (C-3), 
125.2 (o-Ar), 127.9 (p-Ar), 128.4 (m-Ar), 139.9 (i-Ar), 179.0 (C=S). M+•(19) C14H17N2OSCl+•  
Calcd 296.0750 Obsd 296.0756 Other ions m/z (%): 278(12), 171(38), 169(100), 127(33), 
113(11), 111(39), 96(53), 75(21), 68(63), 67(18) 
(5S,8R,8aR)-3-(4-Chlorophenylimino)-perhydro-5,8-methanothiazolo[3,4-a]pyridine (14). It 
was prepared from 13 (2 mmol) as described for tiohydantoines 7. White crystals, mp 184-185 
ºC (EtOH) yield 0.3 g, (55 %); [α] 25D  = +394.0 (c 0.5, MeOH) 
1H NMR (DMSO-d6) δ (ppm): 
1.50 (2H, brm, H-6, H-9), 1.63 (1H, brm, H-6), 1.70-1.75 (2H, m, H-7), 1.81 (1H, brm, H-9), 
2.59 (1H, brs, H-8), 3.23 (1H, brt, J = 12.1 Hz, H-1), 3.62 (1H, brdd, J = 6.5 ,12.1 Hz, H-1), 4.06 
(1H, brm, H-8a), 4.80 (1H, brs, H-5), 7.33, (2H, brm, o-Ar), 7.59 (2H, brd, J = 8.0 Hz, m-Ar). 
13C NMR (DMSO-d6) δ (ppm): 26.8 (C-7), 27.1 (C-6), 37.0 (C-9), 37.5 (C-1), 39.9 (C-8), 64.3 
(C-5) 71.6 (C-8a), 125.4 (o-Ar), 129.3 (m-Ar), 131.1 (p-Ar), 139.0 (i-Ar) , 170.0 (C-3). M+•(100) 
C14H15N2SCl+•  Calcd 278.0644 Obsd 278.0644 Other ions m/z (%): 277(28), 211(10), 169(15), 
41(10) 
3-(4-Nitrophenyl)-perhydro-5,8-methanooxazolo[3,4-a]pyridine (15). To a solution of the 
amino alcohol 12 (300 mg, 2.36 mmol) in 20 mL methanol, p-nitrobenzaldehyde (389 mg, 2.36 
mmol) was added, and the mixture was refluxed for 10 hours. The solvent was then evaporated 
off. The product proved to be a mixture of epimers, of which the two epimers could be separated 
by crystallization from n-hexane.  
(3S,5S,8R,8aR)-15 (major epimer). Yellow crystals, mp 101-102 ºC (n-hexane) yield 0.25 g, 
(41 %); [α] 25D  = −86,7 (c 0.5, MeOH) 1H NMR (DMSO-d6) δ (ppm): 1.10 (1H, brd, J = 9.8 Hz, 
H-9anti), 1.20-1.60 (4H, m, H-7, H-6), 1.67 (1H, dm, J = 9.8 Hz, H-9syn), 2.30 (1H, brs, H-8), 
3.14 (1H, dd, J = 4.8,  7.4 Hz, H-8a), 3.42 (1H, brs, H-5), 3.47 (1H, dd, J = 4.8, 8.9 Hz, H-1), 
3.69 (1H, dd, J = 7.4,  8.9 Hz, H-1), 5.54 (1H, brs, H-3), 7.68, (2H, m, o-Ar), 8.19 (2H, m, m-Ar) 
13C NMR (DMSO-d6) δ (ppm): 26.6 (C-7), 30.1 (C-6), 31.9 (C-9), 40.6 (C-8), 62.0 (C-5), 67.7 
(C-8a), 69.3 (C-1), 95.7 (C-3), 123.1 (m-Ar), 127.8 (o-Ar), 147.0 (p-Ar), 149.2 (i-Ar).  
(3R,5S,8R,8aR)-15 (minor epimer). Yellow crystals, mp 94-195 ºC (n-hexane) yield 0.21 g, (35 
%); [α] 25D  = −80,2 (c 0.5, MeOH)  1H NMR (DMSO-d6) δ (ppm): ): 0.89 (1H, brd, J = 9.5 Hz, H-
9anti), 1.21-1.32 (3H, m, H-7, H-6, H-6), 1.39 (1H, m, H-7), 1.47 (1H, m, H-9syn), 2.36 (1H, 
brd, J = 4.0 Hz, H-8), 2.61 (1H, brm, H-5), 3.28 (1H, dd, J = 7.7, 2.9 Hz, H-8a), 3.70 (1H, dd, J 
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= 8.8, 3.0 Hz, H-1), 3.75 (1H, dd, J = 8.8, 7.7 Hz, H-1), 5.34 (1H, brs, H-3), 7.70 (2H, m, o-Ar), 
8.29 (2H, m, m-Ar). 13C NMR (DMSO-d6) δ (ppm): 26.3 (C-7), 30.4 (C-6), 33.5 (C-9), 41.4 (C-
8), 56.3 (C-5), 67.9 (C-8a), 69.6 (C-1), 94.2 (C-3), 123.4 (m-Ar), 128.0 (o-Ar), 143.6 (i-Ar), 
147.2 (p-Ar). M+•(100) C14H16N2O3+• Calcd 260.1161 Obsd 260.1173 Other ions m/z (%): 
259(15), 231(27), 230(92), 202(21), 138(32), 109(30), 108(38), 94(27), 89(1), 81(36), 80(33), 
77(15), 68(27), 67(39), 66(20), 55(12), 54(43), 53(15), 42(11), 41(37), 39(19)  
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